Clinical trials: Correlate Tracer Uptake to TCell Tumor Infiltration & CkIT Benefit
Correlate Tracer Uptake to TCell Tumor Infiltration & CkIT Benefit
A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors
In this study, patients with advanced solid tumors will undergo [18F]F AraG PET/CT imaging to assess for changes in tracer uptake following treatment with CkIT.
- Trial name
- NCT04260256
- Testing
- [18F]F-AraG
- Where
- 2 sites in United States
- Volunteers
- 9 people
- Sponsor
- CellSight Technologies, Inc.